1. Home
  2. KOPN vs ENTA Comparison

KOPN vs ENTA Comparison

Compare KOPN & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kopin Corporation

KOPN

Kopin Corporation

N/A

Current Price

$4.74

Market Cap

396.8M

Sector

Technology

ML Signal

N/A

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

N/A

Current Price

$14.10

Market Cap

378.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KOPN
ENTA
Founded
1984
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
396.8M
378.0M
IPO Year
2025
2012

Fundamental Metrics

Financial Performance
Metric
KOPN
ENTA
Price
$4.74
$14.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$4.69
$20.40
AVG Volume (30 Days)
4.4M
170.1K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
103.03
29.93
EPS
N/A
N/A
Revenue
$1,530,311.00
$102,814,000.00
Revenue This Year
$50.07
$7.76
Revenue Next Year
$33.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
46.53
16.48
52 Week Low
$1.81
$7.05
52 Week High
$6.61
$17.15

Technical Indicators

Market Signals
Indicator
KOPN
ENTA
Relative Strength Index (RSI) 54.39 58.93
Support Level $4.38 $12.39
Resistance Level $5.53 $15.51
Average True Range (ATR) 0.35 0.62
MACD 0.04 0.06
Stochastic Oscillator 58.21 86.31

Price Performance

Historical Comparison
KOPN
ENTA

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: